First Line Treatment of Metastatic Pancreatic Endocrine Carcinomas with Capecitabine and Temozolomide

被引：0
|
作者：
Strosberg, J. [1 ]
Choi, J. [1 ]
Gardner, N. [1 ]
Kvols, L. [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
NEUROENDOCRINOLOGY | 2009年 / 90卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
93
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [1] First-line treatment of metastatic pancreatic endocrine carcinomas with capecitabine and temozolomide
    Strosberg, J. R.
    Choi, J.
    Gardner, N.
    Kvols, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] First-Line Treatment of Metastatic Pancreatic Endocrine Carcinomas With Capecitabine and Temozolomide
    Strosberg, Jonathan
    Choi, Junsung
    Nasir, Aejaz
    Kvols, Larry
    PANCREAS, 2010, 39 (02) : 280 - 280
  • [3] First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas
    Strosberg, Jonathan R.
    Fine, Robert L.
    Choi, Junsung
    Nasir, Aejaz
    Coppola, Domenico
    Chen, Dung-Tsa
    Helm, James
    Kvols, Larry
    CANCER, 2011, 117 (02) : 268 - 275
  • [4] Metastatic Hepatoid Carcinoma of the Pancreas: First Description of Treatment With Capecitabine and Temozolomide
    Ferreira, Bruna Pellini
    Vasquez, Jonathan
    Carilli, Allison
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (06): : 610 - 612
  • [5] Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma
    Bullock, Andrea
    Stuart, Keith
    Jacobus, Susanna
    Abrams, Thomas
    Wadlow, Raymond
    Goldstein, Michael
    Miksad, Rebecca
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (06) : 945 - +
  • [6] Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
    Wilbur, H. Catherine
    Durham, Jennifer N.
    Lim, Su Jin
    Purtell, Katrina
    Bever, Katherine M.
    Laheru, Daniel A.
    De Jesus-Acosta, Ana
    Azad, Nilofer S.
    Wilt, Bradley
    Diaz, Luis A.
    Le, Dung T.
    Wang, Hao
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (08): : 1672 - 1677
  • [7] Peptide receptor radionuclide therapy versus capecitabine/ temozolomide for the treatment of metastatic pancreatic neuroendocrine tumors
    Gujarathi, R.
    Tobias, J.
    Azar, S. A.
    Keutgen, X.
    Liao, C-Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S94 - S94
  • [8] Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine Tumors
    Gujarathi, Rushabh
    Tobias, Joseph
    Abou Azar, Sara
    Keutgen, Xavier M.
    Liao, Chih-Yi
    CANCERS, 2024, 16 (17)
  • [9] Identification of response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
    Strosberg, Jonathan
    Cives, Mauro
    Brelsford, Marjorie
    Black, Michael
    Meeker, Alan
    Ghayouri, Masoumeh
    CANCER RESEARCH, 2015, 75
  • [10] Identification of response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
    Strosberg, Jonathan R.
    Cives, Mauro
    Brelsford, Marjorie
    Black, Michael
    Meeker, Alan
    Ghayouri, Masoumeh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345